BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24920291)

  • 1. Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.
    Longuini VC; Lourenço DM; Sekiya T; Meirelles O; Goncalves TD; Coutinho FL; Francisco G; Osaki LH; Chammas R; Alves VA; Siqueira SA; Schlesinger D; Naslavsky MS; Zatz M; Duarte YA; Lebrão ML; Gama P; Lee M; Molatore S; Pereira MA; Jallad RS; Bronstein MD; Cunha-Neto MB; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
    Eur J Endocrinol; 2014 Sep; 171(3):335-42. PubMed ID: 24920291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
    Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
    Lindberg D; Akerström G; Westin G
    Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
    Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.
    Malanga D; De Gisi S; Riccardi M; Scrima M; De Marco C; Robledo M; Viglietto G
    Eur J Endocrinol; 2012 Mar; 166(3):551-60. PubMed ID: 22129891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
    Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V;
    J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.
    Marini F; Giusti F; Fossi C; Cioppi F; Cianferotti L; Masi L; Boaretto F; Zovato S; Cetani F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Loli P; Mantero F; Marcocci C; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Guizzardi F; Spada A; Tomassetti P; Tonelli F; Brandi ML
    Endocrine; 2018 Oct; 62(1):215-233. PubMed ID: 29497973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
    Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
    Virchows Arch; 2024 May; 484(5):789-798. PubMed ID: 38244045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.
    Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S;
    Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27kip1: a new multiple endocrine neoplasia gene?
    Marinoni I; Pellegata NS
    Neuroendocrinology; 2011; 93(1):19-28. PubMed ID: 20980721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
    Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
    Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study.
    Shyamasunder AH; Pai R; Ramamoorthy H; Sakhti D; Manipadam MT; Kapoor N; Paul TV; Jebasingh F; Thomas N; Abraham DT; Paul MJ; Chacko AG; Prabhu K; Rajaratnam S
    Horm Metab Res; 2021 Apr; 53(4):245-256. PubMed ID: 33853118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 1 (MEN1) in Austria.
    Weinhäusel A; Kaserer K; Vierhapper H; Niederle B; Haas OA;
    Wien Klin Wochenschr; 2002 Apr; 114(7):252-7. PubMed ID: 12089860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple endocrine neoplasia, the old and the new: a mini review.
    Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
    G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia syndromes associated with mutation of p27.
    Lee M; Pellegata NS
    J Endocrinol Invest; 2013 Oct; 36(9):781-7. PubMed ID: 23800691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p27 variant and corticotropinoma susceptibility: a genetic and in vitro study.
    Sekiya T; Bronstein MD; Benfini K; Longuini VC; Jallad RS; Machado MC; Goncalves TD; Osaki LH; Higashi L; Viana J; Kater C; Lee M; Molatore S; Francisco G; Chammas R; Naslavsky MS; Schlesinger D; Gama P; Duarte YA; Lebrão ML; Zatz M; Meirelles O; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
    Endocr Relat Cancer; 2014 Jun; 21(3):395-404. PubMed ID: 24532476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.